Hydrocortisone alone vs hydrocortisone plus aminogluthethimide: a comparison of the endocrine effects in postmenopausal breast cancer
- 15 April 1984
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 20 (4), 463-469
- https://doi.org/10.1016/0277-5379(84)90230-x
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- A Randomized Trial Comparing Surgical Adrenalectomy with Aminoglutethimide plus Hydrocortisone in Women with Advanced Breast CancerNew England Journal of Medicine, 1981
- Aminoglutethimide Inhibits Extraglandular Estrogen Production in Postmenopausal Women with Breast Carcinoma*Journal of Clinical Endocrinology & Metabolism, 1978
- Source of Estrogen Production in Postmenopausal Women1Journal of Clinical Endocrinology & Metabolism, 1973
- Aminoglutethimide (Elipten-Ciba) as an Inhibitor of Adrenal Steroidogenesis: Mechanism of Action and Therapeutic TrialJournal of Clinical Endocrinology & Metabolism, 1967
- THE EXCRETION OF OESTRONE, PREGNANEDIOL AND PREGNANETRIOL IN BREAST CANCER PATIENTSActa Endocrinologica, 1963
- A comparative evaluation of adrenalectomy and cortisone in the treatment of advanced mammary carcinomaCancer, 1961
- Dexamethasone in advanced breast cancerCancer, 1960
- The use of prednisolone in the treatment of disseminated breast carcinomaCancer, 1958
- CORTISONE-THYROID THERAPY OF METASTATIC MAMMARY CANCERAnnals of Internal Medicine, 1957
- THE USE OF HYDROCORTISONE IN CANCERAnnals of the New York Academy of Sciences, 1955